Skip to main content
. 2007 Nov 5;153(2):358–366. doi: 10.1038/sj.bjp.0707565

Figure 1.

Figure 1

Single-point measurements of knee joint blood flow at a discrete locus on the joint capsule showing typical responses to topical application of the CB2 receptor agonists JWH015 (a) and JWH133 (b). Blood flow gradually rose, with maximal vasodilatation occurring 1.5 min after drug administration. Joint blood flow subsequently returned to control levels by about 4 min.